Muscle Pharm Corporation (MSLPQ)

[Eagle24]

Summary of Statements of Operations

Year Ended December 31 Three Months Ended March 31
2012 2011 2013 2012
(Unaudited)
Sales – Net $ 67,055,215 $ 17,212,636 $ 22,561,227 $ 16,560,680
Loss from operations $ (8,735,811 ) $ (16,220,160 ) $ (721,480 ) $ (727,293 )

Other expense $ (10,216,984 ) $ (7,060,790 ) $ (6,640,501 ) $ (15,308,000 )
Net loss $ (18,952,795 ) $ (23,280,950 ) $ (7,368,049 ) $ (16,035,293 )
Net loss per common share-basic diluted $ (13.00 ) $ (70.30 ) $ (1.78 ) $ (11.23 )
Weighted average number of common shares outstanding – basic and diluted 1,458,757 331,158 4,128,679 1,428,024

Statement of Financial Position

As of March 31
2013

Cash $ 8,482,927
Total Assets $ 20,537,257
Current Liabilities $ 13,309,425
Long-Term Debt $ 506
Stockholders’ equity $ 7,227,326

8